ALX Oncology Exchanges 13,353,384 Common Shares for Pre-Funded Warrants
Bitget2026/10/15 20:56- ALX Oncology agreed October 14, 2026, to exchange 13,353,384 common shares for pre-funded warrants covering the same number of shares.
- Blackstone-affiliated funds account for 12,885,891 shares; RA Capital Healthcare Fund, 213,667; venBio Global Strategic Fund, 253,826.
- The unregistered issuance relies on a Section 3(a)(9) exemption, with settlement expected on or about October 15, 2026.
- Warrants carry a $0.001-per-share exercise price, exercisable from issuance until fully exercised through cash payment or cashless exercise.
- Exercise is subject to 4.99% or 9.99% ownership caps; holders may raise caps to 19.99%, effective 61 days following notice.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WTI Price Forecast: Advances above mid-$98.00s as bullish setup backs additional gains
Abbott (ABT.US) Q3 revenue beats expectations but lowers full-year guidance; plans to spin off its nutrition business for listing
Abbott announced its third-quarter 2026 results on Wednesday. Meanwhile, the company revealed plans to spin off its nutrition business as a new independent publicly listed company.
USD/JPY Price Forecast: Hits one week low as bears eye trading range support near 157.50
Susquehanna raises pre-earnings price targets for chip stocks: AMD (AMD.US), Qualcomm (QCOM.US), etc. receive upward revisions
Susquehanna has adjusted the target prices for chip stocks such as AMD, Intel, and Qualcomm.
Crypto prices
More
